{"database": "lobbying", "table": "lobbying_activities", "rows": [[1145417, "f9afdabd-a168-43fb-b6dc-c606725e3d1c", "Q3", "LOPER CONSULTING LLC", 400545627, "TEVA PHARMACEUTICALS USA", 2011, "third_quarter", "HCR", "implementation of PPACA; generic drug user fee (no bill number); S. 296 Preserving Access to Life-Saving Medications Act of 2011;", "HOUSE OF REPRESENTATIVES,SENATE", 51000, null, 0, 0, "2011-10-07T09:26:04.717000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1145417"], "units": {}, "query_ms": 8.25863698264584, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}